Last reviewed · How we verify
received an ossein-hydroxyapatite complex
Ossein-hydroxyapatite complex provides bioavailable calcium and phosphate minerals along with organic bone matrix components to support bone mineralization and skeletal health.
Ossein-hydroxyapatite complex provides bioavailable calcium and phosphate minerals along with organic bone matrix components to support bone mineralization and skeletal health. Used for Osteoporosis prevention and treatment, Bone health supplementation.
At a glance
| Generic name | received an ossein-hydroxyapatite complex |
|---|---|
| Sponsor | University of Opole |
| Drug class | Bone mineral supplement |
| Modality | Small molecule |
| Therapeutic area | Orthopedics / Bone Health |
| Phase | FDA-approved |
Mechanism of action
This complex combines hydroxyapatite (the inorganic mineral phase of bone) with ossein (the organic collagen-based matrix of bone), mimicking the natural composition of bone tissue. It is designed to be absorbed and incorporated into bone, promoting bone density and strength. The combination of mineral and organic components may enhance bioavailability and osteogenic activity compared to isolated mineral supplements.
Approved indications
- Osteoporosis prevention and treatment
- Bone health supplementation
Common side effects
- Gastrointestinal upset
- Constipation
- Hypercalcemia (with excessive intake)
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: